Vident Advisory LLC increased its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 56.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,194 shares of the semiconductor company's stock after buying an additional 12,004 shares during the quarter. Vident Advisory LLC's holdings in Synopsys were worth $16,111,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in Synopsys in the fourth quarter worth $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Synopsys during the fourth quarter worth $34,000. Sierra Ocean LLC bought a new stake in shares of Synopsys during the fourth quarter worth $39,000. Hazlett Burt & Watson Inc. lifted its position in shares of Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares during the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC lifted its position in shares of Synopsys by 50.8% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company's stock worth $48,000 after purchasing an additional 33 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
SNPS has been the subject of several research analyst reports. Mizuho decreased their target price on Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Wells Fargo & Company decreased their target price on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a research report on Thursday, February 27th. Piper Sandler decreased their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. KeyCorp lifted their price objective on Synopsys from $555.00 to $575.00 and gave the company an "overweight" rating in a report on Tuesday. Finally, Bank of America decreased their price objective on Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a report on Wednesday, April 16th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and an average price target of $614.86.
Read Our Latest Stock Report on SNPS
Insider Buying and Selling at Synopsys
In other news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. This represents a 13.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. The trade was a 11.86% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Synopsys Stock Up 0.4%
Shares of Synopsys stock traded up $2.02 on Thursday, reaching $503.48. The stock had a trading volume of 774,882 shares, compared to its average volume of 1,108,028. The stock has a market capitalization of $77.85 billion, a P/E ratio of 34.67, a P/E/G ratio of 3.23 and a beta of 1.16. The company has a 50 day moving average price of $448.95 and a 200 day moving average price of $489.21. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $624.80.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.